Larimar Therapeutics Inc. (LRMR)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue - - - - - - - - - -
Cost of Revenue 311.00K 272.00K 326.00K 155.00K 78.00K 261.00K 188.00K 212.00K 70.00K -
Gross Profit -311.00K -272.00K -326.00K -155.00K -78.00K -261.00K -188.00K -212.00K -70.00K -
Operating Income -41.76M -36.53M -50.47M -42.80M -23.21M -62.72M -53.88M -57.12M -73.81M -35.53M
Interest Income - - - - - - 996.00K 894.00K 438.00K 28.00K
Pretax Income -36.95M -35.35M -50.64M -42.48M -23.13M -62.97M -52.93M -58.18M -74.29M -36.57M
Net Income -36.95M -34.18M -50.31M -42.33M -23.13M -61.37M -52.03M -57.88M -74.29M -36.57M
Selling & General & Admin 14.09M 12.28M 12.07M 11.40M 2.42M 12.93M 11.95M 17.14M 19.13M 8.14M
Research & Development 27.36M 24.25M 38.40M 31.41M 20.79M 49.53M 41.74M 39.77M 54.62M 27.39M
Other Expenses - 1.17M -171.00K 322.00K 82.00K - - - - -
Operating Expenses 41.76M 36.53M 50.47M 42.80M 23.21M 62.46M 53.69M 56.91M 73.74M 35.53M
Interest Expense - - - - - - 971.00K 347.00K 806.00K -870.00K
Selling & Marketing Expenses - - - - - 12.93M -212.00K -1.15M -70.00K -
Cost & Expenses 41.76M 36.53M 50.47M 42.80M 23.21M 62.72M 53.88M 57.12M 73.81M 35.53M
Income Tax - -1.17M -326.00K -155.00K -93.86K -1.60M -900.00K -300.00K -946.00K -
Shares Outstanding (Basic) 43.90M 25.76M 17.16M 11.88M 9.21M 2.69M 2.29M 2.27M 2.23M 2.42M
Shares Outstanding (Diluted) 43.90M 25.76M 17.16M 11.88M 9.21M 2.69M 2.29M 2.27M 2.23M 2.42M
EPS (Basic) -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14
EPS (Diluted) -0.84 -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14
EBITDA -41.45M -35.08M -50.14M -42.65M -23.14M -60.81M -52.58M -57.44M -73.41M -35.53M
Depreciation & Amortization 311.00K 272.00K 326.00K 155.00K 78.00K 261.00K 188.00K 212.00K 70.00K -